In eight months, a startup called NextMed has emerged as a growing service among many trying to capitalize on the craze for drugs such as Ozempic, Wegovy and Mounjaro that are often prescribed for weight loss.
Run by a founder who graduated from college 14 months ago, the service has web traffic that has surpassed companies like Calibrate Health Inc. and Found Health Inc. that have advertised weight-loss prescriptions for longer. NextMed, whose corporate parent is Helio Logistics Inc., operates with far fewer employees than competitors. Calibrate has hundreds of employees, and Found has around 200.
